ChemoCentryx (CCXI) Reports In-Line Q1 EPS

ChemoCentryx (NASDAQ: CCXI) reported Q1 EPS of ($0.28), in-line with the analyst estimate of ($0.28).

For earnings history and earnings-related data on ChemoCentryx (CCXI) click here.

You May Also Be Interested In

• Are we witnessing a fundamental or speculative rally in the S&P 500?
• Fairfax prices $750 million senior notes offering at 6.200% interest
• Petco Health and Wellness (WOOF) Misses Q1 EPS by 6c